Skip to content
  • Attorneys
  • About Us
    • Reputation
    • History
    • Diversity & Inclusion
    • Pro Bono
  • Legal Services
    • Civil Litigation
      • Alternative Dispute Resolution
      • Appellate
      • Class Actions
      • Complex Business Litigation
      • Employment
      • Entertainment
      • Fraud, Qui Tam, Civil RICO
      • Health Care Litigation
      • Intellectual Property
      • Lawyers and Law Firms
      • Municipalities and Government Entities
      • Real Estate
      • Securities Litigation
    • White Collar Defense & Government Investigations
      • Business and Financial Crimes
      • Environmental
      • Health Care Fraud and Regulatory Enforcement
      • Internal Investigations
      • Securities Fraud and Insider Trading
  • News & Insights
  • Contact

We use cookies to improve your website experience and provide additional security. By continuing to use this website, you agree to the use of cookies. For more information, please see our Cookie Policy.

Bird Marella Bird Marella
Menu
  • Attorneys
  • About Us
    • Reputation
    • History
    • Diversity & Inclusion
    • Pro Bono
  • Legal Services
    • Civil Litigation
      • Class Actions
      • Complex Business Litigation
      • Employment
      • Entertainment
      • Fraud, Qui Tam, Civil RICO
      • Health Care Litigation
      • Intellectual Property
      • Lawyers and Law Firms
      • Real Estate
      • Securities Litigation
    • White Collar Defense &
      Government Investigations
      • Business and Financial Crimes
      • Environmental
      • Health Care Fraud and Regulatory Enforcement
      • Internal Investigations
      • Securities Fraud and Insider Trading
      • Korea Practice
  • News & Insights
  • Contact
Hero Attorneys

Explore what's new at Bird Marella

“At the very top of their game.”

Best Lawyers

Explore
Explore

Home Arrow right Publications Arrow right Page 31

Practice Group
Practice Area
Attorneys

Paul Chan Discusses Class Actions Over Genetically Modified Organisms with Law360

Principal Paul Chan was featured in the Law360 article, “Plaintiffs Eye New Target In ‘All-Natural’ Labeling Battles,” discussing how attorneys have found plaintiffs setting their sights on “all-natural” …

August 15, 2014

Go to the post

Benjamin Gluck Speaks with The New York Times on the Compounded Medicines Industry

Principal Benjamin Gluck was featured in the article, “Pharmacies Turn Drugs Into Profits, Pitting Insurers vs. Compounders,” published by The New York Times discussing the sky-high priced and …

August 15, 2014

Go to the post

Ariel Neuman and Benjamin Gluck Discuss FedEx Indictment in the Daily Journal

Attorneys Ariel Neuman and Benjamin Gluck authored the article, “FedEx Indictment Creates Bad Incentives” published by the Daily Journal. The article discusses the dangerous incentives created by the federal …

August 5, 2014

Go to the post

Posts pagination

  • Previous pagePrevious page
  • 1
  • …
  • 30
  • 31
  • 32
  • …
  • 47
  • Next pageNext page
©2025 Bird, Marella, Rhow, Lincenberg, Drooks, & Nessim, LLP |  All rights reserved.
Disclaimer

|

Privacy & Cookies
Twitter Linkedin
Rendering